337362-21-7 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 5-cyano-2-fluorobenzoate is used as an intermediate in the synthesis of various pharmaceuticals for its reactivity and potential applications as a building block in organic synthesis.
Used in Agrochemical Industry:
Methyl 5-cyano-2-fluorobenzoate is used as an intermediate in the synthesis of agrochemicals for its reactivity and potential applications as a building block in organic synthesis.
Used in Organic Synthesis:
Methyl 5-cyano-2-fluorobenzoate is used as a reagent in the preparation of various fluorinated organic compounds, contributing to its reactivity and potential applications as a building block in organic synthesis.
Used in Research and Development:
Methyl 5-cyano-2-fluorobenzoate can be found in research and development laboratories for its potential applications in the synthesis of pharmaceuticals, agrochemicals, and other fluorinated organic compounds.
Safety Precautions:
It is important to handle Methyl 5-cyano-2-fluorobenzoate with caution, as it may be harmful if swallowed, inhaled, or in contact with skin. Its use should be in compliance with proper safety measures and regulations.
Check Digit Verification of cas no
The CAS Registry Mumber 337362-21-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,7,3,6 and 2 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 337362-21:
(8*3)+(7*3)+(6*7)+(5*3)+(4*6)+(3*2)+(2*2)+(1*1)=137
137 % 10 = 7
So 337362-21-7 is a valid CAS Registry Number.
337362-21-7Relevant academic research and scientific papers
SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS
-
Page/Page column 140, (2011/12/13)
The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthr
NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS
-
Page/Page column 60, (2010/04/23)
Disclosed herein are cannabinoid receptor ligands of formula (I) wherein A1, A5, Rx, X4, and z are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.
NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS
-
Page/Page column 35, (2010/04/23)
The present application relates to cannabinoid receptor ligands of formula (I) wherein X1, A1, Rx, R2, R3, R4, and z are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions.
